90 related articles for article (PubMed ID: 10822301)
1. Novel cell permeable motif derived from the PreS2-domain of hepatitis-B virus surface antigens.
Oess S; Hildt E
Gene Ther; 2000 May; 7(9):750-8. PubMed ID: 10822301
[TBL] [Abstract][Full Text] [Related]
2. A novel system for efficient gene transfer into primary human hepatocytes via cell-permeable hepatitis B virus-like particle.
Brandenburg B; Stockl L; Gutzeit C; Roos M; Lupberger J; Schwartlander R; Gelderblom H; Sauer IM; Hofschneider PH; Hildt E
Hepatology; 2005 Dec; 42(6):1300-9. PubMed ID: 16317706
[TBL] [Abstract][Full Text] [Related]
3. [Expression, purification, and bio-activity analysis of fusion protein HBx-EGFP-TLM].
Shi X; Zhang Y; Zhou X; Lu J; Guo Z; Huang P
Sheng Wu Gong Cheng Xue Bao; 2011 Sep; 27(9):1371-8. PubMed ID: 22117521
[TBL] [Abstract][Full Text] [Related]
4. Inhibition effect produced by dominant negative mutant fusion protein PreS2-TLM-ScFv-HBcDN on HBV replication in vitro.
Liu WX; Zhu HH; Wu W; He JL; Chen Z
J Viral Hepat; 2012 Apr; 19(4):295-300. PubMed ID: 22404728
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric screening of cell-penetrating peptides for their uptake into embryonic and adult stem cells.
Manceur A; Wu A; Audet J
Anal Biochem; 2007 May; 364(1):51-9. PubMed ID: 17379177
[TBL] [Abstract][Full Text] [Related]
6. The hepatitis B virus large surface protein (LHBs) is a transcriptional activator.
Hildt E; Saher G; Bruss V; Hofschneider PH
Virology; 1996 Nov; 225(1):235-9. PubMed ID: 8918553
[TBL] [Abstract][Full Text] [Related]
7. [Identification of hepatitis B virus genotypes in patients with chronic hepatitis B from different nationalities in ethnic minority areas in Yunnan Province, China].
Bian ZQ; Hua ZL; Yan WY; Liu MQ; Wu DY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):681-6. PubMed ID: 16681927
[TBL] [Abstract][Full Text] [Related]
8. Protein transduction with bacterial cytosine deaminase fused to the TLM intercellular transport motif induces profound chemosensitivity to 5-fluorocytosine in human hepatoma cells.
Hillemann A; Brandenburg B; Schmidt U; Roos M; Smirnow I; Lemken ML; Lauer UM; Hildt E
J Hepatol; 2005 Sep; 43(3):442-50. PubMed ID: 15922474
[TBL] [Abstract][Full Text] [Related]
9. [C3d enhances the immune response against HBV-preS2/S following gene immunization in mice].
Guan QD; Wang LX; Guo Q; Zhang JP; Xu W; Wang Y; Xiong SD
Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(2):101-5. PubMed ID: 15774215
[TBL] [Abstract][Full Text] [Related]
10. Non-sequencing molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases.
Raimondo G; Costantino L; Caccamo G; Pollicino T; Squadrito G; Cacciola I; Brancatelli S
J Hepatol; 2004 Mar; 40(3):515-9. PubMed ID: 15123368
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus protein preS2 potentially promotes HCC development via its transcriptional activation of hTERT.
Luan F; Liu H; Gao L; Liu J; Sun Z; Ju Y; Hou N; Guo C; Liang X; Zhang L; Sun W; Ma C
Gut; 2009 Nov; 58(11):1528-37. PubMed ID: 19651630
[TBL] [Abstract][Full Text] [Related]
12. In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase.
Liu H; Luan F; Ju Y; Shen H; Gao L; Wang X; Liu S; Zhang L; Sun W; Ma C
Biochem Biophys Res Commun; 2007 Apr; 355(2):379-84. PubMed ID: 17307151
[TBL] [Abstract][Full Text] [Related]
13. [Expression of HBV preS2/S gene in mammalian cells transferred with adenoviral vector].
Lei CL; Huang CH; Yang Z; Tang XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):55-7. PubMed ID: 16201475
[TBL] [Abstract][Full Text] [Related]
14. Effect of preS2 antisense RNA on hepatocellular carcinoma with a novel delivery system.
Ma C; Sun W; Tian P; Wang X; Liu S; Zhang L; Cao Y; Zhu F; Zhang Q
Chin Med J (Engl); 2003 May; 116(5):717-20. PubMed ID: 12875688
[TBL] [Abstract][Full Text] [Related]
15. Supportive role played by precore and preS2 genomic changes in the establishment of lamivudine-resistant hepatitis B virus.
Ohkawa K; Takehara T; Kato M; Deguchi M; Kagita M; Hikita H; Sasakawa A; Kohga K; Uemura A; Sakamori R; Yamaguchi S; Miyagi T; Ishida H; Tatsumi T; Hayashi N
J Infect Dis; 2008 Oct; 198(8):1150-8. PubMed ID: 18713056
[TBL] [Abstract][Full Text] [Related]
16. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
Gripon P; Cannie I; Urban S
J Virol; 2005 Feb; 79(3):1613-22. PubMed ID: 15650187
[TBL] [Abstract][Full Text] [Related]
17. Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice.
Youm JW; Won YS; Jeon JH; Ryu CJ; Choi YK; Kim HC; Kim BD; Joung H; Kim HS
Vaccine; 2007 Jan; 25(3):577-84. PubMed ID: 16945456
[TBL] [Abstract][Full Text] [Related]
18. Hypermodification and immune escape of an internally deleted middle-envelope (M) protein of frequent and predominant hepatitis B virus variants.
Tai PC; Suk FM; Gerlich WH; Neurath AR; Shih C
Virology; 2002 Jan; 292(1):44-58. PubMed ID: 11878907
[TBL] [Abstract][Full Text] [Related]
19. Transfer of hepatitis B virus genome by adenovirus vectors into cultured cells and mice: crossing the species barrier.
Sprinzl MF; Oberwinkler H; Schaller H; Protzer U
J Virol; 2001 Jun; 75(11):5108-18. PubMed ID: 11333892
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a hepatitis B and hepatitis delta virus receptor binding site.
Engelke M; Mills K; Seitz S; Simon P; Gripon P; Schnölzer M; Urban S
Hepatology; 2006 Apr; 43(4):750-60. PubMed ID: 16557545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
